1. Blog
  2. Post-Weight-Loss Treatments

How to Build a Post-Weight-Loss Restoration Protocol Responsibly

Patients are asking about volume loss and loose skin after weight loss. Here is what the evidence says, and how to build a provider-led offer around it.

As more patients lose weight on GLP-1 medications, clinics are hearing more concerns about facial volume loss and skin laxity. "Ozempic face" is a popular phrase, not a medical diagnosis, and it's worth using careful language with patients.

What the evidence says so far

A 2026 narrative review in Clinics in Dermatology, by researchers at the Icahn School of Medicine at Mount Sinai, covered dermatologic effects of GLP-1 medications, including facial volume loss and skin laxity. It discussed biostimulatory fillers, energy-based devices and nutritional optimization as potential approaches.

Its authors also said more research is needed, including prospective, large-scale clinical studies. So the honest position is that this is a real patient concern with a developing evidence base. Your marketing and consultations should reflect that.

Check what's actually indicated

Know the difference between an approved or cleared indication and an off-label use, for every product in your protocol.

  • Sculptra. The FDA approved it for facial fat loss in people with HIV, and later for cosmetic use for nasolabial fold contour deficiencies and other facial wrinkles. A later supplement covered fine lines and wrinkles in the cheek region.
  • RF microneedling devices. Cleared uses depend on the specific device. Look up the exact wording in the FDA's 510(k) database rather than relying on marketing materials.

Post-weight-loss restoration as such isn't a labeled indication. Your medical director should decide how to handle off-label use and what patients must be told.

Build the protocol around the patient

A sensible protocol starts with a medical consultation, not a package.

  1. Assess the patient. Review their weight-loss history and stability, medications, medical history and photos.
  2. Check candidacy. Decide who shouldn't be treated yet, including patients still actively losing weight if your provider advises waiting.
  3. Address nutrition. Consider protein intake and overall health, and coordinate with the prescribing clinician when appropriate.
  4. Match the treatment. Separate volume concerns from laxity concerns, and be clear about when surgery may be a better route.
  5. Set expectations. Discuss the number of sessions, timing, risks and likely limits of results.
  6. Document everything. Keep informed consent, photos and follow-up records.

Pricing a package fairly

Our calculator models a $3,000 package at a 60% margin. Check that against your own costs: product, provider time, device costs and room time. Offer packages because they fit a treatment plan, and never let a package target override a provider's judgment.

Keep marketing in line with care

Avoid promising specific results or implying that a patient has a problem. See our marketing compliance checklist before you promote this service.

Sources

  1. Practical Dermatology, summary of Hu et al. in Clinics in Dermatology
  2. FDA, Sculptra premarket approval supplement summary
  3. FDA 510(k) premarket notification database

This article is general information, not legal, tax, financial or medical advice. Rules change and vary by state, so confirm how they apply to you with a qualified advisor.